Home / Health / One HPV Shot May Soon Offer Full Cancer Protection
One HPV Shot May Soon Offer Full Cancer Protection
26 Sep
Summary
- Medical experts are considering one HPV vaccine dose instead of two.
- HPV vaccines have significantly reduced cancer rates in vaccinated individuals.
- HPV vaccination rates are lower than other adolescent vaccines.
Medical experts are exploring a significant change to HPV vaccination recommendations, considering whether one dose of the vaccine might suffice instead of the current two.
This potential shift could simplify immunization schedules for preteens and adolescents. Research, including a study from Costa Rica, indicates that a single HPV shot can provide approximately 97% protection against cervical cancer, comparable to two doses.
HPV, a common sexually transmitted infection, is linked to thousands of cancer cases annually, including a high percentage of cervical and anal cancers. The existing HPV vaccines, first approved in 2006, have demonstrated effectiveness in reducing genital warts and precancerous cervical lesions.
Despite evidence showing dramatic decreases in HPV-related health issues and studies indicating vaccinated males have a reduced risk of head and neck cancers, vaccination rates have remained flat, with only about 63% of teenagers receiving both doses. Factors contributing to lower rates include a lack of school mandates and concerns about the vaccine's sting.
Currently, experts advise children to receive two doses, as the evidence for one dose's sufficiency for all types of cancer and for boys is still developing. Regardless of the final recommendation, experts stress the importance of vaccination due to its clear cancer-preventing benefits.
